NDC 61958-3002

Sunlenca

Lenacapavir Sodium

Sunlenca is a Kit in the Human Prescription Drug category. It is labeled and distributed by Gilead Sciences. The primary component is .

Product ID61958-3002_e2f725c8-d250-42e1-bb62-249cf99bcb28
NDC61958-3002
Product TypeHuman Prescription Drug
Proprietary NameSunlenca
Generic NameLenacapavir Sodium
Dosage FormKit
Marketing Start Date2022-12-22
Marketing CategoryNDA /
Application NumberNDA215973
Labeler NameGilead Sciences
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2024-12-31

Packaging

NDC 61958-3002-1

1 KIT in 1 CARTON (61958-3002-1) * 1.5 mL in 1 VIAL (61958-3004-1)
Marketing Start Date2022-12-22
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Sunlenca" or generic name "Lenacapavir Sodium"

NDCBrand NameGeneric Name
61958-3001SunlencaLENACAPAVIR SODIUM
61958-3002SunlencaLENACAPAVIR SODIUM

Trademark Results [Sunlenca]

Mark Image

Registration | Serial
Company
Trademark
Application Date
SUNLENCA
SUNLENCA
88823358 not registered Live/Pending
Gilead Sciences Ireland UC
2020-03-05

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.